glp 1 and b12 deficiency 22% of people on GLP-1 medications become nutrient deficient in Main effects and mechanisms of

Low vitamin levels can slow down metabolism and cause weight issues like obesity

Ipamorelin Within the Research Peptide Catalogue Ipamorelin occupies the ghrelin receptor agonist / GHRP position within our GH-axis research toolkit mechanistically complementary to, and synergistic with, the GHRH-axis compounds CJC-1295 No DAC and tesamorelin, and distinct from the direct GH replacement approach of rhGH

Combines tirzepatide with glycine and vitamin B12 in one formulation

and other PASC manifestations (ageusia, anosmia, parosmia, skin rashes) 130,131

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, commonly causes gastrointestinal effects including nausea, diarrhea, and constipation